Diabetes is a particularly difficult autoimmune condition, with a high risk of complications and a resulting heavy load of demands. Even though modern medicine enables patients to keep this disease under control, there is currently no way to prevent or reverse it with conventional treatments.
Stemwell stem cell therapy for diabetes directly addresses the underlying issues that cause the patient’s body to misregulate its glucose levels.
Type 1 diabetes (T1D), also known as insulin-dependent diabetes, is a chronic condition in which the pancreas produces little to no insulin.
Modern medicine has yet to explain why pancreatic islet cells simply stop producing insulin in sufficient quantities to maintain a normal blood glucose level. Research has shown, however, that by targeting the tiny blood vessels that oxygenate the pancreas, it is possible to regenerate tissue, promote new vessel growth, and thus sustain and restore insulin production and distribution.
In stem cell treatment for diabetes, mesenchymal stem cells derived from the umbilical cord can repair pancreatic damage and promote the regeneration of insulin-producing cells.
In a healthy person, insulin, which is produced in the pancreas, aids in the absorption of glucose, allowing sugar to be converted into fuel energy or stored for later use. The body relies on the presence of insulin to maintain healthy blood sugar levels.
Type 1 diabetes occurs when the body’s immune system ruthlessly destroys the pancreas’s insulin-producing beta cells (b-cells), leaving the body unable to produce insulin on its own.
Type 2 diabetes, the more common form, is distinguished by insulin resistance, a condition in which various tissues in the body no longer respond to insulin produced. There is a subsequent progressive decline in b-cell function, to the point where the cells no longer produce enough additional insulin to overcome the insulin resistance.
Diabetes is a major problem because it usually leads to other diseases and complications. Whether your body does not produce insulin (Type 1 diabetes) or is insulin resistant (Type 2 diabetes), it is probably not properly regulating your blood-glucose levels. This can lead to long-term complications such as heart disease, stroke, diabetic neuropathy, and kidney failure.
A combination of stem and regenerative cells has been shown to repair cells, increase blood flow, and reduce inflammation. It has also been shown to be extremely effective in stopping damaging immune responses and restoring the body to normal function.
Type 1 diabetes, also known as insulin-dependent diabetes, is a chronic disease in which the pancreas produces little to no insulin and the immune system destroys insulin-producing cells as well as the blood vessels that support them. Stemwell processed stem cells repair and replace damaged insulin-producing cells and blood vessels.
Stemwell uses cord tissue-derived mesenchymal stem cells ethically sourced from full-term human umbilical cords. We administer more than 300 million cells that are all thoroughly tested for viability before treatment. These cells are NOT a blood product; therefore, it is extremely safe and does not require HLA or phenotypic matching.
Video call with one of our doctors, where patient’s condition and medical history will be discussed.
The patient undergoes an initial evaluation and blood work by Stemwell’s doctor. The patient is later sent to rest at their hotel.
Application of 3 Million x Kg of weight distributed in 2 intrathecal applications, under sedation in the surgery room and two endogenous applications.
Oral Detox in children.
5 sessions – Hyberbaric chamber
(xxmin per session)
5 sessions – Transcranial Magnetotherapy
(45min per session)
5 sessions Biophotomodulation
(30min per session)
Because human umbilical cord tissue mesenchymal stem cells (HUCT-MSCs) are immune system privileged, cell rejection is not an issue, and human leukocyte antigen (HLA) matching is not required. We screen and select stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration. Allogeneic stem cells can be administered in uniform doses with high cell counts multiple times over the course of several days.
Umbilical cord tissue provides an abundant supply of MSCs. There is no need to collect stem cells from the patient’s hip bone or fat under anesthesia, which can be a traumatic experience for small children and their parents. A growing body of evidence suggests that MSCs derived from umbilical cord tissue are more robust than MSCs derived from other sources.
There is no need to administer chemotherapy drugs such as Granulocyte-colony stimulating factor (G-CSF or GCSF) to stimulate bone marrow production of granulocytes and stem cells and their release into the bloodstream.
Stemwell’s adult stem cells are derived from human umbilical cord tissue and are used to treat autoimmune diseases (allogeneic mesenchymal). These stem cells are expanded in our cutting-edge laboratory.
The mesenchymal stem cells (MSCs) we use are recovered from donated umbilical cords following normal, healthy births. Each mother’s medical history is checked, and she is tested for infectious diseases. Prior to donation, each family provides written consent.
Before being approved for use in patients, all umbilical cord-derived stem cells are tested for infectious diseases in accordance with International Blood Bank Standards.
Only a small percentage of donated umbilical cords make it through our stringent screening process.
Our mission is to bring hope, healing, and a personalized plan to every patient we meet. We believe the caring hands and expertise of our doctors along with our proven protocols provide the best possible outcomes. We follow the highest ethical international standards offering transparency, honesty, and clinical accuracy.
AddressCra. 13 #118-08, Bogotá, Colombia
Free Toll Phone: +1 (833) 783-6935
Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other medical treatments. Reviewing the patient’s medical history is necessary to determine stem cell therapy eligibility. Any personal information provided is for internal and medical use with our medical providers only. The Stemwell Health headquarters is located in McLean, Virginia. Stemwell Health Virginia is not a stem cell treatment facility or surgical center. Treatments are not conducted anywhere in the US, since these advanced therapies are not yet FDA-approved. All cell therapies are conducted in Colombia where it is regulated by the ministry of health, INVIMA (Columbia’s FDA equivalent) and other local authorities. All treatments are performed within the country’s legal limits and regulatory framework where the specific medical provider practices.